Skip to main content
Top

05-22-2018 | Insulin | Article

Perceptions of insulin use in type 2 diabetes in primary care: a thematic synthesis

Journal: BMC Family Practice

Authors: Kathy Ellis, Henrietta Mulnier, Angus Forbes

Publisher: BioMed Central

Abstract

Background

Increasing numbers of patients with type 2 diabetes mellitus are progressing to insulin therapy, and despite its potency many such individuals still have suboptimal glycaemic control. Insulin initiation and intensification is now often conducted by Practice Nurses and General Practitioners in many parts of the UK. Therefore, gaining insight into perspectives of patients and primary care clinicians is important in determining self-management and engagement with insulin. A thematic synthesis of studies was conducted exploring the views and experiences of people with type 2 diabetes and of healthcare professionals on insulin use and management in the context of primary care.

Methods

Protocol based systematic searches of electronic databases (CINAHL, Cochrane Library, EMBASE, MEDLINE, PsycINFO, and Web of Science) were performed on 1 October 2014 and updated on 31 March 2015, to identify studies that identified the views and experiences of adults with type 2 diabetes or primary care clinicians on the use of insulin in the management of type 2 diabetes. Studies meeting the review inclusion criteria were critically appraised using the CASP qualitative research checklist or Barley’s checklist for survey designs. A thematic synthesis was then conducted of the collected studies.

Results

Thirty-four studies were selected. Of these, 12 used qualitative interviews (nine with patients and three with healthcare professionals) and 22 were survey based (14 with patients, three with healthcare professionals, and five with both). Twelve key themes were identified and formed three domains, patient perceptions, healthcare professional perceptions, and health professional-patient relationships. The patient-centred themes were: insulin-related beliefs, social influences, psychological factors, hypoglycaemia, and therapy barriers. The clinician-related themes were: insulin skills of general practitioners, healthcare integration, healthcare professional-perceived barriers, hypoglycaemia, and explanations for adherence. Healthcare professional-patient relationship themes were drawn from the perspectives of patients and from clinicians.

Conclusions

This review reveals multiple barriers to optimal insulin use in primary care at both the patient and healthcare professional levels. These barriers indicate the need for multimodal interventions to: improve the knowledge and competencies of primary care professionals in insulin use; provide more effective patient education and self-management support; and introduce integrated insulin support systems.
Literature
1.
Diabetes UK. Diabetes: facts and stats. 2016; https://​www.​diabetes.​org.​uk/​. Accessed 19 Dec 2017.
2.
Evans ML, Sharplin P, Owens DR, Chamberlain GH, Longman AJ, McEwan P. Insulin usage in type 2 diabetes mellitus patients in UK clinical practice: a retrospective cohort-based analysis using the THIN database. British J Diab Vasc Dis. 2010;10(4):178–82. CrossRef
3.
Mulnier H, Seaman H, Lovell D, Lawrenson R. The increasing proportion of patients with type 2 diabetes converting to insulin therapy. Practical Diabetes International. 2005;22(6):202–6. CrossRef
4.
Dale J, Martin S, Gadsby R. Insulin initiation in primary care for patients with type 2 diabetes: 3-year follow-up study. Primary Care Diabetes. 2010;4(2):85–9. PubMedCrossRef
5.
Burden ML, Burden AC. Attitudes to starting insulin in primary care. Practical Diabetes International. 2007;24(7):346–50. CrossRef
6.
Chadder L. An evaluation of insulin training for GPs and practice nurses. Journal of Diabetes Nursing. 2013;17(4):141–7.
7.
Ellis K, Pinnock H, Apampa B. Insulin initiation in a general practice clinic: a questionnaire-based study. Diabetes & Prim Care. 2011;13(3):181–9.
8.
Zafar A, Stone MA, Davies MJ, Khunti K. Acknowledging and allocating responsibility for clinical inertia in the management of type 2 diabetes in primary care: a qualitative study. Diabet Med. 2015;32(3):407–13. PubMedCrossRef
9.
Bahrmann A, Abel A, Zeyfang A, Petrak F, Kubiak T, Hummel J, Oster P, Bahrmann P. Psychological insulin resistance in geriatric patients with diabetes mellitus. Patient Educ Couns. 2014;94(3):417–22. PubMedCrossRef
10.
Davies MJ, Gagliardino JJ, Gray LJ, Khunti K, Mohan V, Hughes R. Real-world factors affecting adherence to insulin therapy in patients with type 1 or type 2 diabetes mellitus: a systematic review. Diabet Med. 2013;30(5):512–24. PubMedCrossRef
11.
Holman RR, Paul SK, Bethel MA, Matthews DR, Haw N. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577–89. PubMedCrossRef
12.
Paul SK, Klein K, Thorsted BL, Wolden ML, Khunti K. Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes. Cardiovasc Diabetol. 2015;14(1):1–10. CrossRef
13.
Barendse S, Singh H, Frier BM, Speight J. The impact of hypoglycaemia on quality of life and related patient reported outcomes in type 2 diabetes: a narrative review. Diabet Med. 2012;29(3):293–302. PubMedCrossRef
14.
Campbell R, Pound P, Pope C, Britten N, Pill R, Morgan M, Donovan J. Evaluating meta-ethnography: a synthesis of qualitative research on lay experiences of diabetes and diabetes care. Soc Sci Med. 2003;56(4):671–84. PubMedCrossRef
15.
Khunti K, Davies M, Kalra S. Self-titration of insulin in the management of people with type 2 diabetes: a practical solution to improve management in primary care. Diabetes. Obes Metab. 2013;15(8):690–700. CrossRef
16.
Gherman A, Veresiu IA, Sassu RA, Schnur JB, Scheckner BL, Montgomery GH. Psychological insulin resistance: a critical review of the literature. Practical Diabetes International. 2011;28(3):125–8. CrossRef
17.
Lustman PJ, Clouse RE. Depression in diabetic patients: the relationship between mood and glycemic control. J Diabetes Complicat. 2005;19(2):113–22.
18.
Pontiroli AE, Miele L, Morabito A. Increase of body weight during the first year of intensive insulin treatment in type 2 diabetes: systematic review and meta-analysis. Diabetes. Obes Metab. 2011;13(11):1008–19. CrossRef
19.
Britten N, Campbell R, Pope C, Donovan J, Morgan M, Pill R. Using meta ethnography to synthesise qualitative research: a worked example. J. Health Serv. Res. Policy. 2002;7(4):209–15. PubMedCrossRef
20.
Dixon-Woods M, Agarwal S, Jones D, Young B, Sutton A. Synthesising qualitative and quantitative evidence: a review of possible methods. Journal of Health Service Research and Policy. 2005;10(1):45–53. CrossRef
21.
Forbes A, Griffiths P. Methodological strategies for the identification and synthesis of 'evidence' to support decision-making in relation to complex healthcare systems and practices. Nurs Inq. 2002;9(3):141–55. PubMedCrossRef
22.
Mohammed MA, Moles RJ, Chen TF. Meta-synthesis of qualitative research: the challenges and opportunities. Int J Clin Pharm. 2016;38(3):695–704. PubMed
23.
Noblit GW, Hare RD. Meta-ethnography: synthesizing qualitative studies. London: Sage; 1988. CrossRef
24.
Pedersen VH, Dagenais P, Lehoux P. Multi-source synthesis of data to inform health policy. Int J Technol Assess Health Care. 2011;27(3):238–46. PubMedCrossRef
25.
Walsh D, Downe S. Meta-synthesis method for qualitative research: a literature review. J Adv Nurs. 2005;50(2):204–11. PubMedCrossRef
26.
Thomas J, Harden A. Methods for the thematic synthesis of qualitative research in systematic reviews. BMC Med Res Methodol. 2008;8:45. PubMedPubMedCentralCrossRef
27.
Carroll C. Qualitative evidence synthesis to improve implementation of clinical guidelines. Br Med J. 2017;356:108–10.
28.
Barley EA, Murray J, Walters P, Tylee A. Managing depression in primary care: a meta-synthesis of qualitative and quantitative research from the UK to identify barriers and facilitators. BMC Fam Pract. 2011;12:47. PubMedPubMedCentralCrossRef
29.
Mold F, Forbes A. Patients' and professionals' experiences and perspectives of obesity in health-care settings: a synthesis of current research. Health Expect. 2013;16(2):119–42. PubMedCrossRef
30.
Lopez KA, Willis DG. Descriptive versus interpretive phenomenology: their contributions to nursing knowledge. Qual Health Res. 2004;14(5):726–35. PubMedCrossRef
31.
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and Meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–9. PubMedCrossRef
32.
Tong A, Flemming K, McInnes E, Oliver S, Craig J. Enhancing transparency in reporting the synthesis of qualitative research: ENTREQ. BMC Med Res Methodol. 2012;12:181. PubMedPubMedCentralCrossRef
33.
Cronin P, Ryan F, Coughlan M. Undertaking a literature review: a step-by-step approach. Br J Nurs. 2008;17(1):38–43. PubMedCrossRef
34.
Whiting L. Systematic review protocols: an introduction. Nurse Res. 2009;17(1):34–43. PubMedCrossRef
35.
Critical Appraisal Skills Programme (CASP) Qualitative checklist. 2013; https://​casp-uk.​net/​/. Accessed 13 Aug 2016.
36.
Abu Hassan H, Tohid H, Mohd Amin R, Long Bidin MB, Muthupalaniappen L, Omar K. Factors influencing insulin acceptance among type 2 diabetes mellitus patients in a primary care clinic: a qualitative exploration. BMC Fam Pract. 2013;14:164. PubMedPubMedCentralCrossRef
37.
Brod M, Pohlman B, Kongso JH. Insulin administration and the impacts of forgetting a dose. Patient. 2014;7:63–71. PubMedCrossRef
38.
Brown K, Avis M, Hubbard M. Health beliefs of African-Caribbean people with type 2 diabetes: a qualitative study. Br J Gen Pract. 2007;57(539):461–9. PubMedPubMedCentral
39.
Browne JL, Ventura A, Mosely K, Speight J. 'I call it the blame and shame disease': a qualitative study about perceptions of social stigma surrounding type 2 diabetes. BMJ Open. 2013;3:e003384. https://​doi.​org/​10.​1136/​bmjopen-2013-003384. PubMedPubMedCentralCrossRef
40.
Hortensius J, Kars MC, Wierenga WS, Kleefstra N, Bilo HJ, van der Bijl JJ. Perspectives of patients with type 1 or insulin-treated type 2 diabetes on self-monitoring of blood glucose: a qualitative study. BMC Public Health. 2012;12:167. PubMedPubMedCentralCrossRef
41.
Janes R, Titchener J, Pere J, Pere R, Senior J. Understanding barriers to glycaemic control from the patient's perspective. Journal of Primary Health Care. 2013;5(2):114–22. PubMed
42.
Jenkins N, Hallowell N, Farmer AJ, Holman RR, Lawton J. Participants' experiences of intensifying insulin therapy during the treating to target in Type2 diabetes (4-T) trial: qualitative interview study. Diabet Med. 2011;28(5):543–8. PubMedCrossRef
43.
Ong WM, Chua SS, Ng CJ. Barriers and facilitators to self-monitoring of blood glucose in people with type 2 diabetes using insulin: a qualitative study. Patient Preference and Adherence. 2014;8:237–46. PubMedPubMedCentral
44.
Vinter-Repalust N, Petricek G, Katic M. Obstacles which patients with type 2 diabetes meet while adhering to the therapeutic regimen in everyday life: qualitative study. Croat. Med. J. 2004;45(5):630–6. PubMed
45.
Goderis G, Borgermans L, Mathieu C, Van den Broeke C, Hannes K, Heyrman J, Grol. Barriers and facilitators to evidence based care of type 2 diabetes patients: experiences of general practitioners participating to a quality improvement program. Implement Sci. 2009;4:41. PubMedPubMedCentralCrossRef
46.
Jeavons D, Hungin APS, Cornford CS. Patients with poorly controlled diabetes in primary care: healthcare clinicians' beliefs and attitudes. Postgrad Med J. 2006;82(967):347–50. PubMedPubMedCentralCrossRef
47.
Lee YK, Ng CJ, Lee PY, Khoo EM, Abdullah KL, Low WY, Samad AA, Chen WS. What are the barriers faced by patients using insulin? A qualitative study of Malaysian health care professionals' views. Patient Preference and Adherence. 2013;7:103–9. PubMedPubMedCentralCrossRef
48.
Ary DV, Toobert D, Wilson W, Glasgow RE. Patient perspective on factors contributing to nonadherence to diabetes regimen. Diabetes Care. 1986;9(2):168–72. PubMedCrossRef
49.
Brod M, Rana A, Barnett AH. Impact of self-treated hypoglycaemia in type 2 diabetes: a multinational survey in patients and physicians. Curr Med Res Opin. 2012a;28(12):1947–58. PubMedCrossRef
50.
Brod M, Rana A, Barnett AH. Adherence patterns in patients with type 2 diabetes on basal insulin analogues: missed, mistimed and reduced doses. Curr Med Res Opin. 2012b;28(12):1933–46. PubMedCrossRef
51.
Brod M, Christensen T, Bushnell DM. Impact of nocturnal hypoglycemic events on diabetes management, sleep quality, and next-day function: results from a four-country survey. J Med Econ. 2012c;15(1):77–86. PubMedCrossRef
52.
Brod M, Wolden M, Christensen T, Bushnell DM. A nine country study of the burden of non-severe nocturnal hypoglycaemic events on diabetes management and daily function. Diabetes Obesity and Metabolism. 2013a;15(6):546–57. CrossRef
53.
Cefalu WT, Mathieu C, Davidson J, Freemantle N, Gough S, Canovatchel W. Patients' perceptions of subcutaneous insulin in the OPTIMIZE study: a multicenter follow-up study. Diabetes Technol. Ther. 2008;10(1):25–38. PubMedCrossRef
54.
Cuddihy RM, Philis-Tsimikas A, Nazeri A. Type 2 diabetes care and insulin intensification: is a more multidisciplinary approach needed? Results from the modify survey. Diabetes Educator. 2011;37(1):111–23. PubMedCrossRef
55.
Diago-Cabezudo JI, Madec-Hily A, Aslam A. Perceptions of hypoglycemia and self-monitoring of blood glucose in insulin-treated diabetes patients: results from a European online survey. Diabetes Management. 2013;3(1):15–23. CrossRef
56.
Fulcher G, Singer J, Castañeda R, Fraige Filho F, Maffei L, Snyman J, Brod M. The psychosocial and financial impact of non-severe hypoglycemic events on people with diabetes: two international surveys. J Med Econ. 2014;17(10):751–61. PubMedCrossRef
57.
Leiter LA, Yale J-F, Chiasson J-L, Harris S, Kleinstiver P, Sauriol L. Assessment of the impact of fear of hypoglycemic episodes on glycemic and hypoglycemia management. Can J Diabetes. 2005;29(3):186–92.
58.
Leiter LA, Boras D, Woo VC. Dosing irregularities and self-treated hypoglycemia in type 2 diabetes: results from the Canadian cohort of an international survey of patients and healthcare professionals. Can J Diabetes. 2014;38:38–44. PubMedCrossRef
59.
Mehmet S, Hussey C, Ibrahim S. Patients’ perceptions of injecting insulin and self-monitoring of blood glucose in the presence of others. Practical Diabetes. 2015;32(2):59–63. CrossRef
60.
Mitchell BD, Vietri J, Zagar A, Curtis B, Reaney M. Hypoglycaemic events in patients with type 2 diabetes in the United Kingdom: associations with patient-reported outcomes and self-reported HbA1c. BMC Endocr Disord. 2013;13:59. PubMedPubMedCentralCrossRef
61.
Mollema E, Snoek F, Ader HJ, Heine R, van der Ploeg H. Insulin-treated diabetes patients with fear of self-injecting or fear of self-testing: psychological comorbidity and general well-being. J Psychosom Res. 2001;51(5):665–72. PubMedCrossRef
62.
Mosnier-Pudar H, Hochberg G, Eschwege E, Virally ML, Halimi S, Guillausseau PJ, Peixoto O, Touboul C, Dubois C, Dejager S. How do patients with type 2 diabetes perceive their disease? Insights from the French DIABASIS survey. Diabetes & Metabolism. 2009;35(3):220–7. CrossRef
63.
Peyrot M, Barnett AH, Meneghini LF, Schumm-Draeger PM. Factors associated with injection omission/non-adherence in the global attitudes of patients and physicians in insulin therapy study. Diabetes Obes. Metab. 2012a;14(12):1081–7. PubMedCrossRef
64.
Peyrot M, Barnett AH, Meneghini LF, Shumm-Draeger PM. Insulin adherence behaviours and barriers in th1e multinational global attitudes of patients and physicians in insulin therapy study. Diabet Med. 2012b;29(5):682–9. PubMedPubMedCentralCrossRef
65.
Rubin RR, Peyrot M, Kruger DF, Travis LB. Barriers to insulin injection therapy: patient and health care provider perspectives. The Diabetes Educator. 2009;35(6):1014–22. PubMedCrossRef
66.
Shiu AT. Sense of coherence amongst Hong Kong Chinese adults with insulin-treated type 2 diabetes. Int J Nurs Stud. 2004;41(4):387–96. PubMedCrossRef
67.
Siminerio LM, Funnell MM, Peyrot M, Rubin RR. US Nurses' perceptions of their role in diabetes care: results of the cross-national diabetes attitudes wishes and needs (DAWN) study. Diabetes Educ. 2007;33(1):152–62. PubMedCrossRef
68.
Van Avendonk MJ, Gorter KJ, van den Donk M, Rutten GE. Insulin therapy in type 2 diabetes is no longer a secondary care activity in the Netherlands. Primary Care Diabetes. 2009;3:23–8. PubMedCrossRef
69.
Zambanini A, Newson RB, Maisey M, Feher MD. Injection related anxiety in insulin-treated diabetes. Diabetes Research & Clinical Practice. 1999;46(3):239–46. CrossRef
70.
Fu AZ, Qiu Y, Radican L. Impact of fear of insulin or fear of injection on treatment outcomes of patients with diabetes. Curr Med Res Opin. 2009;25(5):1413–20. PubMedCrossRef
71.
Khunti K, Nikolajsen A, Thorsted BL, Andersen M, Davies MJ, Paul SK. Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin. Diabetes. Obes Metab. 2016;18(4):401–9. CrossRef
72.
Ritholz MD, Beverly EA, Abrahamson MJ, Brooks KM, Hultgren BA, Weinger K. Physicians' perceptions of the type 2 diabetes multidisciplinary treatment team a qualitative study. Diabetes Educator. 2011;37(6):794–800. PubMedCrossRef
73.
Munro N, Barnard KD, Brice R, Cummings M, Davies M, Hall G. Discordant perceptions regarding the interactions between people with diabetes and healthcare professionals in the UK: findings from the DAWN2 study, Research poster. 14th annual conference of the South Asian Health Foundation; 2013. p. 21–2. http://​www.​diabetesonthenet​.​com/​. Accessed 7 Nov 2014.
74.
Yoshioka N, Ishii H, Tajima N, Iwamoto Y. Differences in physician and patient perceptions about insulin therapy for management of type 2 diabetes: the DAWN Japan study. Curr Med Res Opin. 2014;30(2):177–83. PubMedCrossRef
75.
Serrano V, Rodriguez-Gutierrez R, Hargraves I, Gionfriddo MR, Tamhane S, Montori VM. Shared decision-making in the care of individuals with diabetes. Diabet Med. 2016;33(6):742–51. PubMedCrossRef
76.
Frier BM, Jensen MM, Chubb BD. Hypoglycaemia in adults with insulin-treated diabetes in the UK: self-reported frequency and effects. Diabet Med. 2016;33(8):1125–32. PubMedCrossRef
77.
Grammes J, Stock W, Mann CG, Flynn EM, Kubiak T. Focus group study to identify the central facets of fear of hypoglycaemia in people with type 2 diabetes mellitus. Diabet Med. 2017;34(12):1765–72. PubMedCrossRef
78.
Krall J, Gabbay R, Zickmund S, Hamm ME, Williams KR, Siminerio L. Current perspectives on psychological insulin resistance: primary care provider and patient views. Diabetes Technol Ther. 2015;17(4):268–74. PubMedCrossRef
79.
McBain H, Begum S, Rahman S, Mulligan K. Barriers to and enablers of insulin self-titration in adults with type 2 diabetes: a qualitative study. Diabet Med. 2016;34(2):253–61. PubMedCrossRef
80.
Tong WT, Vethakkan SR, Ng CJ. Why do some people with type 2 diabetes who are using insulin have poor glycaemic control? A qualitative study. BMJ Open. 2015;5(1) https://​doi.​org/​10.​1136/​bmjopen-2014-006407.
81.
Donnelly LA, Morris AD, Evans JMM. Adherence to insulin and its association with glycaemic control in patients with type 2 diabetes. QJ Med. 2007;100(6):345–50. CrossRef
82.
Ho PM, Rumsfeld JS, Masoudi FA, McClure DL, Plomondon ME, Steiner JF, Magid DJ. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166(17):1836–41. PubMedCrossRef
83.
Aloumanis K, Benroubi M, Sourmeli S, Drossinos V. Clinical outcomes and costs for patients with type 2 diabetes mellitus initiating insulin therapy in Greece: two-year experience from the INSTIGATE study. Primary Care Diabetes. 2013;7(3):235–42. PubMedCrossRef
84.
Balkau B, Bouee S, Avignon A, Verges B, Chartier I, Amelineau E, Halimi S. Type 2 diabetes treatment intensification in general practice in France in 2008-2009: the DIAttitude study. Diabetes & Metabolism. 2012;38(Suppl 3):S29–35. CrossRef
85.
Beresford C. Patients’ perspectives of type 2 diabetes care by practice nurses: a qualitative study. J Diabetes Nurs. 2011;15(10):391–7.
86.
Beverly EA, Ritholz MD, Brooks KM, Hultgren BA, Lee Y, Abrahamson MJ, Weinger K. A qualitative study of perceived responsibility and self-blame in type 2 diabetes: reflections of physicians and patients. J Gen Intern Med. 2012;27(9):1180–7. PubMedPubMedCentralCrossRef
87.
Brod M, Pohlman B, Wolden M, Christensen T. Non-severe nocturnal hypoglycaemic events: experience and impacts on patient functioning and well-being. Qual Life Res. 2013b;22(5):997–1004. PubMedCrossRef
88.
Carbone ET, Rosal MC, Torres MI, Goins KV, Bermudez OI. Diabetes self-management: perspectives of Latino patients and their health care providers. Patient Educ Couns. 2007;66(2):202–10. PubMedCrossRef
89.
Chai J, Anderson C, Wong KT, Hussein Z. Patients’ lived-experience of insulin therapy for type 2 diabetes management. Conference abstract. Res Soc Adm Pharm. 2012;8:e29–30. CrossRef
90.
Chai J, Anderson C, Wong KT, Hussein Z. Injecting insulin? How TOUGH can it be? Research poster. RPS annual conference 8-9 September 2013, Birmingham UK. Int J Pharm Pract. 2013;21(Suppl 2):32–3.
91.
Chai J, Anderson C, Wong KT, Hussein Z. Social stigma affecting non-adherence of insulin therapy for type 2 diabetes Management in Malaysia. Conference Abstract Res. Social Adm. Pharm. 2014;10:e53. CrossRef
92.
Chan CMF, Liau Wei F, Teo NHL, Toh MP, Chen S. Understanding the perception of patients with type 2 diabetes on insulin therapy at primary healthcare setting in Singapore. Singapore. Nurs J. 2014;41(2):23–8.
93.
Choudhury S, Das S, Hazra A. Survey of knowledge-attitude-practice concerning insulin use in adult diabetic patients in eastern India. Indian J Pharmacol. 2014;46(4):425–9. PubMedPubMedCentralCrossRef
94.
Cramer JA, Pugh MJ. The influence of insulin use on Glycaemic control. How well do adults follow prescriptions for insulin? Diabetes Care. 2005;28(1):78–83. PubMedCrossRef
95.
Gaborit B, Dutour O, Ronsin O, Atlan C, Darmon P, Gharsalli R, Pradel V, Dadoun F, Dutour A. Ramadan fasting with diabetes: an interview study of inpatients' and general practitioners' attitudes in the south of France. Diabetes and. Metabolism. 2011;37(5):395–402.
96.
Hermanns N, Mahr M, Kulzer B, Skovlund SE, Haak T. Barriers towards insulin therapy in type 2 diabetic patients: results of an observational longitudinal study. Health Qual Life Outcomes. 2010;8:113. PubMedPubMedCentralCrossRef
97.
Hinder S, Greenhalgh T. This does my head in ethnographic study of self-management by people with diabetes. BMC Health Serv Res. 2012;12:83. PubMedPubMedCentralCrossRef
98.
Frei A, Herzog S, Woitzek K, Held U, Senn O, Rosemann T, Chmiel C. Characteristics of poorly controlled type 2 diabetes patients in Swiss primary care. Cardiovasc Diabetol. 2012;11:70. PubMedPubMedCentralCrossRef
99.
Hunt LM, Valenzuela MA, Pugh JA. Porque me Toco a mi? Mexican American diabetes patients' causal stories and their relationship to treatment behaviours. Soc Sci Med. 1998;46(8):959–69. PubMedCrossRef
100.
Khattab M, Khader YS, Al-Khawaldeh A, Ajlouni K. Factors associated with poor glycemic control among patients with type 2 diabetes. J Diabetes Complicat. 2010;24(2):84–9. CrossRef
101.
Lai WA, Chie WC, Lew-Ting CY. How diabetic patients' ideas of illness course affect non-adherent behaviour: a qualitative study. Br J Gen Pract. 2007;57(537):296–302. PubMedPubMedCentral
102.
Lakkis NA, Maalouf GJ, Mahmassani DM, Hamadeh GN. Insulin therapy attitudes and beliefs of physicians in middle eastern Arab countries. Fam Pract. 2013;30(5):560–7. PubMedCrossRef
103.
Mollem ED, Snoek FJ, Heine RJ. Assessment of perceived barriers in self-care of insulin requiring diabetic patients. Patient Educ Couns. 1996;29(3):277–81. PubMedCrossRef
104.
Morris J, Povey R, Street C. Experiences of people with type 2 diabetes who have changed from oral medication to self-administered insulin injections. Pract Diabetes Int. 2005;22(7):239–43. CrossRef
105.
Oliveria SA, Menditto LA, Yood MU, Koo YH, Wells KE, McCarthy BD. Barriers to the initiation of, and persistence with, insulin therapy. Curr Med Res Opin. 2007;23(12):3105–12. PubMedCrossRef
106.
Peyrot M, Rubin RR, Lauritzen T, Skovlund SE, Snoek FJ, Matthews DR, Landgraf R, Kleinebreil L. Resistance to insulin therapy among patients and providers: results of the cross-national diabetes attitudes, wishes, and needs (DAWN) study. Diabetes Care. 2005;28(11):2673–9. PubMedCrossRef
107.
Peyrot M, Rubin RR, Lauritzen T, Skovlund SE, Snoek FJ, Matthews DR, Landgraf R. Patient and provider perceptions of care for diabetes: results of the cross-national DAWN study. Diabetologia. 2006;49(2):279–88. PubMedCrossRef
108.
Peyrot M, Burns KK, Davies M, Forbes A, Hermanns N, Holt R, Kalra S, Nicolucci A, Pouwer F, Wens J, Willaing I, Skovlund SE. Diabetes attitudes wishes and needs 2 (DAWN2): a multinational, multi-stakeholder study of psychosocial issues in diabetes and person-centred diabetes care. Diabetes Res Clin Pract. 2013;99(2):174–84. PubMedCrossRef
109.
Pooley CG, Gerrard C, Hollis S, Morton S, Astbury J. ‘Oh it’s a wonderful practice … you can talk to them’: a qualitative study of patients’ and health professionals’ views on the management of type 2 diabetes. Health Soc. Care Community. 2001;9(5):318–26. PubMedCrossRef
110.
Shiu ATY, Wong RYM. Fear of hypoglycaemia among insulin-treated Hong Kong Chinese patients: implications for diabetes patient education. Patient Educ Couns. 2000;41(3):251–61. PubMedCrossRef
111.
Thomson FJ, Masson EA, Leeming JT, Boulton AJM. Lack of knowledge of symptoms of Hypoglycaemia by elderly diabetic patients. Age Ageing. 1991;20:404–6. PubMedCrossRef
112.
Wendel CS, Fotieo GG, Shah JH, Felicetta J, Curtis BH, Murata GH. Incidence of non-severe hypoglycaemia and intensity of treatment among veterans with type 2 diabetes in the USA: a prospective observational study. Diabet Med. 2014;31(12):1524–31. PubMedCrossRef
113.
Wong S, Lee J, Ko Y, Chong MF, Lam CK, Tang WE. Perceptions of insulin therapy amongst Asian patients with diabetes in Singapore. Diabet Med. 2011;28(2):206–11. PubMedCrossRef

Be confident that your patient care is up to date

Medicine Matters is being incorporated into Springer Medicine, our new medical education platform. 

Alongside the news coverage and expert commentary you have come to expect from Medicine Matters diabetes, Springer Medicine's complimentary membership also provides access to articles from renowned journals and a broad range of Continuing Medical Education programs. Create your free account »